| Labatec Pharma SA - Bimatoprost Labatec 0.3 mg/ml, collyre en solution |
| 68391 | | 01 | | Bimatoprost Labatec 0.3 mg/ml | | collyre en solution | | S01EE03 | | Bimatoprost | | 22.04.2022 | | |
|
| Composition |
| bimatoprostum 0.30 mg, benzalkonii chloridum 0.05 mg, acidum citricum monohydricum, dinatrii phosphas heptahydricus corresp. phosphas 0.95 mg, natrii chloridum, acidum hydrochloridum aut natrii hydroxidum ad pH, aqua ad iniectabile ad solutionem pro 1 ml. |
| Packungsbestandteile |
| collyre en solution | | | | | | Active Agent | Dose |
|---|
| Bimatoprost | 0.3 mg/ml |
| | | | Inactive agents | Dose |
|---|
| Citric Acid Monohydrate | | | Acidum Hydrochloridum aut Natrii Hydroxidum ad Ph | | | Benzalkonium Chloride | 0.05 mg/ml | | Disodium Phosphate Heptahydrate | | | Sodium Chloride | |
|
|
| Package number | Package Size | EFP | CP | Category | SL | Out of trade (MedRef) |
|---|
| 001 | 3 ml | PR | PR | B | | Yes |
|
